Online ISSN: 1947-6027
www.genesandcancer.com
About Genes & Cancer
Our mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways. We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development.

LEARN MORE ABOUT GENES & CANCER

Genes & Cancer | Expression of HOTAIR and MEG3 are negatively associated with H. pylori positive status in gastric cancer patients

Genes & Cancer

November 18, 2022
PRESS RELEASE: A new research paper was published in Genes & Cancer on February 10, 2022, entitled, “Expression of HOTAIR and MEG3 are negatively associated with H. pylori positive status in gastric cancer patients.” continue reading »

The Role of CDKs in Breast Cancer Among Women in Pakistan

Genes & Cancer

October 28, 2022
Researchers examined the mRNA expression levels of six CDKs in Pakistani women with pre- and postmenopausal breast cancer with lung metastasis. continue reading »

Genes & Cancer | Splice modulating oligomers as cancer therapeutics

Genes & Cancer

October 14, 2022
PRESS RELEASE: A new editorial paper was published in Genes & Cancer on August 26, 2022, entitled, “Splice modulating oligomers as cancer therapeutics.” continue reading »

Behind the Study: Reaching Beyond Family History as Inclusion Criteria for Pancreatic Cancer Surveillance in High-risk Populations

Genes & Cancer

October 6, 2022
Dr. Louise Wang from Yale School of Medicine and the VA Connecticut Healthcare system, describes a recent editorial she co-authored that was published by Genes & Cancer, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.” continue reading »

Genes & Cancer | Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations

Genes & Cancer

September 30, 2022
PRESS RELEASE: A new editorial paper was published in Genes & Cancer on August 29, 2022, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.” continue reading »